Brief: Cabaletta Bio Reports Q1 2023 Financial Results And Provides Business Update
May 11 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* EXPECTS THAT ITS CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2023,
WILL ENABLE IT TO FUND ITS OPERATING PLAN INTO Q1 OF 2025
* QTRLY NET LOSS PER SHARE OF VOTING AND NON-VOTING COMMON
STOCK,
BASIC AND DILUTED $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9YrQtC
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview